Barriers to Access: An Assessment of Stakeholder Risks and Incentives in the Value Chain for Artemisinin Combination Therapy (ACT) Treatments

15 Pages Posted: 26 Aug 2007

See all articles by Prashant Yadav

Prashant Yadav

Harvard Medical School

Neelam Sekhri

Healthcare Redesign Group

Kirsten Anne Curtis

MIT-Zaragoza Logistics Program

Date Written: June 2007

Abstract

Artemisinin combination therapy is being widely advocated as a first line treatment for malarial in Sub-Saharan Africa and other parts of the world where traditional chloroquine therapies are no longer effective. Various bilateral and multilateral donors assist countries in procurement of treatments, but serious barriers prevent increase in patient access. These barriers are related to the dysfunctional global health value chain of ACTs and by the risks and incentives faced by a range of stakeholders in this value chain, from manufacturers to health service providers. This analysis uses value chain expertise to examine the ACT market by systematically analyzing how risks and rewards are shared among stakeholders in the public sector value chain for ACTs and proposes ways to correct imbalances which will result in increased access to these life saving drugs.

Keywords: Public Health Policy, Incentive Alignment, Artemisinin Combination Therapy, Global Health Supply Chains

Suggested Citation

Yadav, Prashant and Sekhri, Neelam and Curtis, Kirsten Anne, Barriers to Access: An Assessment of Stakeholder Risks and Incentives in the Value Chain for Artemisinin Combination Therapy (ACT) Treatments (June 2007). Available at SSRN: https://ssrn.com/abstract=1008307 or http://dx.doi.org/10.2139/ssrn.1008307

Prashant Yadav (Contact Author)

Harvard Medical School ( email )

25 Shattuck St
Boston, MA 02115
United States

Neelam Sekhri

Healthcare Redesign Group ( email )

Alameda, CA
United States

Kirsten Anne Curtis

MIT-Zaragoza Logistics Program ( email )

Avenida Gomez Laguna 25
Zaragoza, 50009
Spain

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
244
Abstract Views
1,882
rank
138,967
PlumX Metrics